Subacute sclerosing panencephalitis and multiple sclerosis: in vitro measles immunity and sensitization to myelin basic protein

William Sheremata, A. Sazant, G. Watters

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Three children with subacute sclerosing panencephalitis (SSPE), 12 patients with multiple sclerosis (MS) and 12 healthy persons were studied by the macrophage migration inhibition factor (MIF) assay with measles and rubella antigens and with myelin basic protein. For the SSPE patients the mean migration indexes ± standard deviation were 44.1 ± 10.9 for measles antigen, 38.7 ± 12.3 for rubella antigen and 49.8 ± 25.7 for myelin basic protein; for the MS patients the indexes were 103.0 ± 10.6, 93.8 ± 15.0 and 89.3 ± 19.9; and for the healthy subjects the indexes were 68.8 ± 22.6, 77.7 ± 31.3 and 100.4 ± 6.5. The results of this study showed increased cellular immunity to measles and rubella in SSPE patients as compared with healthy persons, and absence of immunity to measles in MS patients. Patients with MS showed hypersensitivity to myelin basic protein during clinical exacerbations that was not associated with changes in immunity to measles, whereas all SSPE patients showed a significant response regardless of stage of illness.

Original languageEnglish
Pages (from-to)509-513
Number of pages5
JournalCanadian Medical Association Journal
Volume118
Issue number5
StatePublished - Jan 1 1978
Externally publishedYes

Fingerprint

Subacute Sclerosing Panencephalitis
Myelin Basic Protein
Measles
Multiple Sclerosis
Immunity
Rubella
Antigens
Macrophage Migration-Inhibitory Factors
In Vitro Techniques
Cellular Immunity
Healthy Volunteers
Hypersensitivity

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Subacute sclerosing panencephalitis and multiple sclerosis : in vitro measles immunity and sensitization to myelin basic protein. / Sheremata, William; Sazant, A.; Watters, G.

In: Canadian Medical Association Journal, Vol. 118, No. 5, 01.01.1978, p. 509-513.

Research output: Contribution to journalArticle

@article{9890f447cb504691bbe5c320ab3e51cf,
title = "Subacute sclerosing panencephalitis and multiple sclerosis: in vitro measles immunity and sensitization to myelin basic protein",
abstract = "Three children with subacute sclerosing panencephalitis (SSPE), 12 patients with multiple sclerosis (MS) and 12 healthy persons were studied by the macrophage migration inhibition factor (MIF) assay with measles and rubella antigens and with myelin basic protein. For the SSPE patients the mean migration indexes ± standard deviation were 44.1 ± 10.9 for measles antigen, 38.7 ± 12.3 for rubella antigen and 49.8 ± 25.7 for myelin basic protein; for the MS patients the indexes were 103.0 ± 10.6, 93.8 ± 15.0 and 89.3 ± 19.9; and for the healthy subjects the indexes were 68.8 ± 22.6, 77.7 ± 31.3 and 100.4 ± 6.5. The results of this study showed increased cellular immunity to measles and rubella in SSPE patients as compared with healthy persons, and absence of immunity to measles in MS patients. Patients with MS showed hypersensitivity to myelin basic protein during clinical exacerbations that was not associated with changes in immunity to measles, whereas all SSPE patients showed a significant response regardless of stage of illness.",
author = "William Sheremata and A. Sazant and G. Watters",
year = "1978",
month = "1",
day = "1",
language = "English",
volume = "118",
pages = "509--513",
journal = "CMAJ",
issn = "0008-4409",
publisher = "Canadian Medical Association",
number = "5",

}

TY - JOUR

T1 - Subacute sclerosing panencephalitis and multiple sclerosis

T2 - in vitro measles immunity and sensitization to myelin basic protein

AU - Sheremata, William

AU - Sazant, A.

AU - Watters, G.

PY - 1978/1/1

Y1 - 1978/1/1

N2 - Three children with subacute sclerosing panencephalitis (SSPE), 12 patients with multiple sclerosis (MS) and 12 healthy persons were studied by the macrophage migration inhibition factor (MIF) assay with measles and rubella antigens and with myelin basic protein. For the SSPE patients the mean migration indexes ± standard deviation were 44.1 ± 10.9 for measles antigen, 38.7 ± 12.3 for rubella antigen and 49.8 ± 25.7 for myelin basic protein; for the MS patients the indexes were 103.0 ± 10.6, 93.8 ± 15.0 and 89.3 ± 19.9; and for the healthy subjects the indexes were 68.8 ± 22.6, 77.7 ± 31.3 and 100.4 ± 6.5. The results of this study showed increased cellular immunity to measles and rubella in SSPE patients as compared with healthy persons, and absence of immunity to measles in MS patients. Patients with MS showed hypersensitivity to myelin basic protein during clinical exacerbations that was not associated with changes in immunity to measles, whereas all SSPE patients showed a significant response regardless of stage of illness.

AB - Three children with subacute sclerosing panencephalitis (SSPE), 12 patients with multiple sclerosis (MS) and 12 healthy persons were studied by the macrophage migration inhibition factor (MIF) assay with measles and rubella antigens and with myelin basic protein. For the SSPE patients the mean migration indexes ± standard deviation were 44.1 ± 10.9 for measles antigen, 38.7 ± 12.3 for rubella antigen and 49.8 ± 25.7 for myelin basic protein; for the MS patients the indexes were 103.0 ± 10.6, 93.8 ± 15.0 and 89.3 ± 19.9; and for the healthy subjects the indexes were 68.8 ± 22.6, 77.7 ± 31.3 and 100.4 ± 6.5. The results of this study showed increased cellular immunity to measles and rubella in SSPE patients as compared with healthy persons, and absence of immunity to measles in MS patients. Patients with MS showed hypersensitivity to myelin basic protein during clinical exacerbations that was not associated with changes in immunity to measles, whereas all SSPE patients showed a significant response regardless of stage of illness.

UR - http://www.scopus.com/inward/record.url?scp=0017811519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017811519&partnerID=8YFLogxK

M3 - Article

C2 - 343902

AN - SCOPUS:0017811519

VL - 118

SP - 509

EP - 513

JO - CMAJ

JF - CMAJ

SN - 0008-4409

IS - 5

ER -